Guardant Health, Inc. (Nasdaq: GH), a leading precision oncology company, today announced that on February 11, 2025, the ...

Guardant Health (NASDAQ:GH – Get Free Report) had its target price upped by Piper Sandler from $34.00 to $50.00 in a report ...

Fear and anxiety may be the key reasons why patients are choosing not to undergo screenings for colorectal cancer. A study conducted by the Harris Poll and Palo Alto, Calif-based Guardant Health asked ...

Globant S.A. , a digitally native technology services company (the "Company"), announced today that it filed its annual report on Form 20-F for the year ended December 31, 2024 (the "2024 Annual ...

Canopy Growth Corporation ("Canopy Growth" or the "Company") , a world-leading cannabis company dedicated to unleashing the ...

Researchers conduct a retrospective, population-based cohort study of adult patients with metastatic breast cancer who underwent genomic profiling at academic institutions.

In a report released today, William Bonello from Craig-Hallum maintained a Buy rating on Natera (NTRA – Research Report). The company’s shares ...

There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Rhythm Pharmaceuticals (RYTM – Research Report), ...

The "43rd Annual JP Morgan Healthcare Conference, January 13-16, 2025" report has been added to ResearchAndMarkets.com's offering.The 43rd Annual JP Morgan Healthcare Conference took place in San ...

Plug and Play Warsaw’s Medtech Expo will be 1:30 to 5:30 p.m. March 5 at Grace College’s Manahan Orthopaedic Capital Center. Registering for the event is free, but must be done in advance at ...